Category Archives: Blog

The Pfizer-BioNTech Vaccine Is Said to Be Powerfully Protective in Adolescents

The Coronavirus Outbreak liveLatest Updates Maps and Cases Risk Near You Who Can Get Vaccinated? Vaccine Rollout Advertisement Continue reading the main story Supported by Continue reading the main story The Pfizer-BioNTech Vaccine Is Said to Be Powerfully Protective in Adolescents A clinical trial found no symptomatic infections among vaccinated children ages 12 to 15,… Read More »

Young Adults Having Less Casual Sex

By Amy Norton HealthDay Reporter TUESDAY, March 30, 2021 (HealthDay News) — Despite being the dating-app generation, young adults are largely saying no to casual sex, and less drinking and more video games are two reasons why, a new study suggests. Surveys in recent years have been finding that compared with past generations, today’s young… Read More »

Ask the doctor: I drink eight bottles of wine a week and I want to quit. Should I cut down gradually or go cold turkey?

Q: I drink a lot, far more than the recommended amount and have done so for about 10 years. I would easily put away eight bottles of wine a week, in addition to a couple of beers here and there and the odd whiskey. I have promised my wife I will address it but she… Read More »

All About PSA: Everything You Need to Know

First of all, what is PSA? PSA is a term that stands for prostate-specific antigen. PSAs are proteins that are created in the prostate tissue and are enzymes that free the sperm from the semen after ejaculation. These PSAs can be used to screen for prostate cancer. The History of PSAs The FDA approved PSA… Read More »

FDA Approves New Indication & New Product Formulation for Myrbetriq for Use in Children with Neurogenic Detrusor Overactivity (NDO)

TOKYO, March 26, 2021 /PRNewswire/ — Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas”) announced today that the U.S. Food and Drug Administration (FDA) approved Myrbetriq (mirabegron extended-release tablets) for the treatment of NDO in pediatric patients aged three years and older who weigh 35 kg or more, and Myrbetriq Granules… Read More »